Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06030531
Other study ID # STU00210582
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date July 1, 2020
Est. completion date December 31, 2024

Study information

Verified date September 2023
Source Shirley Ryan AbilityLab
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Spasticity is one of the most common symptoms manifested in humans with spinal cord injury (SCI). However, the neural mechanisms underlying the development of spasticity over time after an acute SCI are not yet understood. Using electrophysiological and imaging techniques along with traditional measurements of neurological recovery in the acute rehabilitation setting including physical exam and functional assessments; the investigators aim to examine the relationship between development of spasticity, residual descending motor pathways and functional and neurological recovery in humans with SCI from acute to subacute phase


Description:

The purpose of this study is to measure changes to motor-evoked potentials (MEPs) and to evaluate if the development of spasticity is related to residual descending motor pathways and to a better neurological recovery and functional improvement in individuals with SCI from the acute to the subacute phase. The investigators will also test for the presence of biological markers in the blood that may correlate with levels of spasticity or neurological recovery and functional improvement, including the presence or absence of neuroplastic genetic polymorphisms (e.g. BDNF Val66Met polymorphism), as well as circulating levels of neuroplastic (e.g. BDNF) or inflammatory factors (e.g. interleukins, TNF) that may affect neuronal growth and functional restoration.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 240
Est. completion date December 31, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Individuals with SCI: Inclusion criteria: - Male and females 18 years of age or greater - Basic proficiency in English language communication - Are admitted to the Shirley Ryan AbilityLab as a spinal cord injury patient - International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) level above L2 - American Spinal Cord Injury Association Impairment Scale (AIS) grades A, B, C, or D - Patients with SCI within the first week of inpatient admission to the Shirley Ryan AbilityLab after sustaining a SC Exclusion criteria: - Under 18 years of age - Severe cognitive impairment that precludes the ability to participate in a comprehensive physical exam or give verbal consent - ISNCSCI level below L2 - People who have sustained SCI >30 days - Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease - Any debilitating disease prior to the SCI that caused exercise intolerance - Premorbid, ongoing major depression or psychosis, altered cognitive status - History of head injury or stroke - Vascular, traumatic, tumoral, infectious, or metabolic lesion of the brain, even without history of seizure, and without anticonvulsant medication - History of seizures or epilepsy - Ongoing cord compression or a syrinx in the spinal cord or people who suffer from a spinal cord disease such as spinal stenosis, spina bifida, MS, or herniated disk 13. Metal plate in skull - Individuals with scalp shrapnel, cochlear implants, or aneurysm clips - Skull fractures, skull deficits or concussion within the last 6 months - Presence of orthoses and presence of spinal precautions or healing incisions that make the area inaccessible to the testing procedures. This criterion will be applied as needed for the specific study procedures that may need to access the areas under restriction. - Formal diagnosis of Post-Traumatic Stress Disorder (PTSD) Individuals in the control group: Inclusion criteria: 1. Male and females 18 years of age or greater 2. Basic proficiency in English language communication Exclusion criteria: 1. Under 18 years of age 2. Uncontrolled medical problems including pulmonary, cardiovascular, or orthopedic disease 3. History of neurological impairment or conditions affecting the Central Nervous System 4. Premorbid, ongoing major depression or psychosis, altered cognitive status 5. Pregnancy

Study Design


Intervention

Other:
Measures of spasticity, connectivity and analysis of single nucleotide polymorphisms and biomarkers of inflammation
We will test for presence of biological markers in blood that may correlate with levels of spasticity or neurological recovery and functional improvement, including the presence or absence of neuroplastic genetic polymorphisms (e.g. BDNF Val66Met polymorphism), as well as circulating levels of neuroplastic(e.g. BDNF) or inflammatory factors (e.g. interleukins, TNF) that may affect neuronal growth and functional restoration.
Analysis of biomarkers
We will test for the presence of biological markers in the blood to compare the distribution of polymorphisms and biomarkers with the spinal cord injury patient population.

Locations

Country Name City State
United States Shirley Ryan AbilityLab Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Shirley Ryan AbilityLab

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Modified Ashworth scale (MAS) This clinical scale will be used by measuring resistance encountered during manual passive muscle stretching using a six-point ordinal scale (0=no increase in tone, 1/+1=slight increase in tone with a catch and release or minimal resistance at the end or less than half of the range of movement, respectively, 2=more marked increased tone through most of the range of movement but affected parts easily moved, 3=considerable increase in tone and passive movement difficultly, and 4=affected parts rigid) From the time of admission to the hospital and enrolled in the study till the time of discharge (up to 12 weeks)
Primary Motor evoked potential (MEP) Transcranial magnetic stimulation will be delivered and the coil will be positioned over the vertex and moved around this point to determine the optimal position for eliciting a motor evoked potentials (MEPs) in legs muscles. From the time of admission to the hospital and enrolled in the study till the time of discharge (up to 12 weeks)
Primary First swing test (FST) We will use the pendulum test to measure muscle tone at the knee by using gravity to provoke muscle stretch reflexes during passive swinging of the lower limb. From the time of admission to the hospital and enrolled in the study till the time of the discharge (up to 12 weeks)
Secondary International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) At the time of the admission, after obtaining consent, and at the time of discharge, the chart will be reviewed to obtain the ISNCSCI score From the time of admission to the hospital and enrolled in the study till the time of discharge (up to 12 weeks)
Secondary Circulating biomarkers of inflammation and neuroplasticity In this study, we will focus on tracking expression of key inflammatory cytokines that have been shown to play a pivotal role in activating the major nuclear factor kappa-B (NF-?B) inflammatory pathway. Specifically, we will characterize serum levels of pro-inflammatory cytokines interleukin-1 beta (IL-1ß), interleukin-6 (IL-6), tumor necrosis factor (TNF-a) and anti-inflammatory marker interleukin-10 (IL-10). We will also measure levels of circulating neuroplasticity marker Brain-derived neurotrophic factor (BDNF) From the time of admission to the hospital and enrolled in the study till the time of discharge (up to 12 weeks)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06321172 - Muscle and Bone Changes After 6 Months of FES Cycling N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05484557 - Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury N/A
Suspended NCT05542238 - The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury N/A
Recruiting NCT05503316 - The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System N/A
Not yet recruiting NCT05506657 - Early Intervention to Promote Return to Work for People With Spinal Cord Injury N/A
Recruiting NCT03680872 - Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System N/A
Recruiting NCT04105114 - Transformation of Paralysis to Stepping Early Phase 1
Completed NCT04221373 - Exoskeletal-Assisted Walking in SCI Acute Inpatient Rehabilitation N/A
Completed NCT00116337 - Spinal Cord Stimulation to Restore Cough N/A
Completed NCT03898700 - Coaching for Caregivers of Children With Spinal Cord Injury N/A
Recruiting NCT04883463 - Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury N/A
Active, not recruiting NCT04881565 - Losing Balance to Prevent Falls After Spinal Cord Injury (RBT+FES) N/A
Completed NCT04864262 - Photovoice for Spinal Cord Injury to Prevent Falls N/A
Recruiting NCT04007380 - Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI N/A
Active, not recruiting NCT04544761 - Resilience in Persons Following Spinal Cord Injury
Terminated NCT03170557 - Randomized Comparative Trial for Persistent Pain in Spinal Cord Injury: Acupuncture vs Aspecific Needle Skin Stimulation N/A
Completed NCT03220451 - Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients N/A
Recruiting NCT04811235 - Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial N/A
Recruiting NCT04736849 - Epidural and Dorsal Root Stimulation in Humans With Spinal Cord Injury N/A